|
TVTX Travere Therapeutics Inc 1438533 |
| Balance Sheet |
|
Current Assets
|
$615,141,000.00 |
|
Assets
|
$799,360,000.00 |
|
Current Liabilities
|
$152,025,000.00 |
|
Liabilities
|
$774,838,000.00 |
|
Equity
|
$24,522,000.00 |
|
Shares Out
|
94174767.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$17,705,000.00 |
|
Investing Cash Flow
|
$-184,738,000.00 |
| Market Analysis |
Market Cap
|
$6,070,505,480.82 |
|
Price
|
$64.46 |
|
BVPS
|
0.26 |
|
PB
|
247.92 |
|
EPS
|
-0.37 |
|
PS
|
8.95 |
|
FCF
|
$17,330,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:15 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-19 |
0.37 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-04 |
0.05 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.13 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
0.59 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TVTX documents filed with the SEC.
TVTX Filings
Clear
